ELIMINATION OF CYSTICERCOSIS IN PER
Phase 1
- Conditions
- Taeniasis-B68 Taeniasis-B690 Cysticercosis of central nervous systemCysticercosis of central nervous systemB68B690
- Registration Number
- PER-002-05
- Lead Sponsor
- BILL & MELINDA GATES FOUNDATION,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 103554
Inclusion Criteria
- Resident of the rural areas of Tumbes, Talara and Sullana (who stays at least two nights in the
community)
- Resident over two years.
Exclusion Criteria
- Residents who refuse to participate in the study.
- Women in gestation will not receive massive treatment of niclosamide.
- Participants with a history of adverse effects to nidosamide will not participate in the mass treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br>Outcome name:Application of 6 different models for the control of taeniasis in human and porcine population. After this the 2 most successful models of intervention are applied at large scale<br>Measure:Development and evaluation of a new control strategy for the treatment of taeniasis and human and porcine neurocysticercosis<br>Timepoints:48 months<br>
- Secondary Outcome Measures
Name Time Method